Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Diabetes Mellitus and SLC5A2[original query] |
|---|
| Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes. Pharmacogenetics and genomics 2017 Jan . Zimdahl Heike, Haupt Axel, Brendel Michael, Bour Louis, Machicao Fausto, Salsali Afshin, Broedl Uli C, Woerle Hans-Juergen, Häring Hans-Ulrich, Staiger Hara |
| Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis. Bioscience reports 2019 Apr . Drexel Heinz, Leiherer Andreas, Saely Christoph H, Brandtner Eva Maria, Geiger Kathrin, Vonbank Alexander, Fraunberger Pater, Muendlein Ax |
| Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus. Journal of diabetes investigation 2020 9 12 (5): 728-737. Monobe Keisuke, Noso Shinsuke, Babaya Naru, Hiromine Yoshihisa, Taketomo Yasunori, Niwano Fumimaru, Yoshida Sawa, Yasutake Sara, Minohara Tatsuro, Kawabata Yumiko, Ikegami Hiros |
| Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patients. Journal of diabetes and metabolic disorders 2021 12 20 (2): 1407-1413. Jamalizadeh Mahdieh, Hasanzad Mandana, Sarhangi Negar, Sharifi Farshad, Nasli-Esfahani Ensieh, Larijani Bagh |
| SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study. Cardiovascular diabetology 2023 10 22 (1): 278. Jiang Li, Yuefeng Yu, Ying Sun, Bowei Yu, Xiao Tan, Bin Wang, Yingli Lu, Ningjian Wa |
| Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response. Molecular biology reports 2023 10 . Bo Xu, Shaoqian Li, Bo Kang, Shangzhi Fan, Canyu Chen, Weiyi Li, Jixiang Chen, Zunbo He, Fan Tang, Jiecan Zh |
| The Impact of Genetic Polymorphisms on the Anti-Hyperglycemic Effect of Dapagliflozin. Diabetes, metabolic syndrome and obesity : targets and therapy 2024 8 17 2881-2894. Zi Wang, Xiaoyu Li, Qing Xu, Yao Yao, Xiaoye Li, Hongmei Yan, Qianzhou |
| Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study. Frontiers in pharmacology 2024 8 15 1443045. Yilong Lin, Yue Zhang, Songsong Wang, Lin Cao, Ruidan Zhao, Xilai Ma, Qiaolu Yang, Liyi Zhang, Qingmo Ya |
- Page last reviewed:Feb 1, 2024
- Content source: